in Human Arteries and Veins Systemic Regulation of Vascular NAD ( P ) H Oxidase Activity and Nox Isoform Expression

Tomasz J. Guzik, Jerzy Sadowski, Boguslaw Kapelak, Andrzej Jopek, Pawel Rudzinski, Ravi in Human Arteries and Veins Systemic Regulation of Vascular NAD(P)H Oxidase Activity and Nox Isoform Expression Print ISSN: 1079-5642. Online ISSN: 1524-4636 Copyright © 2004 American Heart Association, Inc. All rights reserved. Greenville Avenue, Dallas, TX 75231 is published by the American Heart Association, 7272 Arteriosclerosis, Thrombosis, and Vascular Biology doi: 10.1161/01.ATV.0000139011.94634.9d 2004;24:1614-1620; originally published online July 15, 2004; Arterioscler Thromb Vasc Biol. http://atvb.ahajournals.org/content/24/9/1614 World Wide Web at: The online version of this article, along with updated information and services, is located on the http://atvb.ahajournals.org/content/suppl/2004/09/10/24.9.1614.DC1.html Data Supplement (unedited) at:

[1]  Tzung K Hsiai,et al.  Pulsatile Versus Oscillatory Shear Stress Regulates NADPH Oxidase Subunit Expression: Implication for Native LDL Oxidation , 2003, Circulation research.

[2]  P. Pagano,et al.  c-Src and smooth muscle NAD(P)H oxidase: assembling a path to hypertrophy. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[3]  O. Carretero,et al.  Novel NAD(P)H Oxidase Inhibitor Suppresses Angioplasty-Induced Superoxide and Neointimal Hyperplasia of Rat Carotid Artery , 2003, Circulation research.

[4]  D. Harrison,et al.  Electron Spin Resonance Characterization of Vascular Xanthine and NAD(P)H Oxidase Activity in Patients With Coronary Artery Disease: Relation to Endothelium-Dependent Vasodilation , 2003, Circulation.

[5]  Amir Lerman,et al.  Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[6]  D. Harrison,et al.  Vascular Oxidative Stress and Endothelial Dysfunction in Patients With Chronic Heart Failure: Role of Xanthine-Oxidase and Extracellular Superoxide Dismutase , 2002, Circulation.

[7]  O. Carretero,et al.  Perivascular Superoxide Anion Contributes to Impairment of Endothelium-Dependent Relaxation: Role of gp91phox , 2002, Circulation.

[8]  K. Hirata,et al.  Superoxide Generation in Directional Coronary Atherectomy Specimens of Patients With Angina Pectoris: Important Role of NAD(P)H Oxidase , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[9]  E. Schiffrin,et al.  Expression of a Functionally Active gp91phox-Containing Neutrophil-Type NAD(P)H Oxidase in Smooth Muscle Cells From Human Resistance Arteries: Regulation by Angiotensin II , 2002, Circulation research.

[10]  K. Channon,et al.  Nitric Oxide Modulates Superoxide Release and Peroxynitrite Formation in Human Blood Vessels , 2002, Hypertension.

[11]  K. Channon,et al.  Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus: Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase , 2002, Circulation.

[12]  W. R. Taylor,et al.  Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis , 2002, Circulation.

[13]  A. Goldfine,et al.  Inhibition of Protein Kinase C&bgr; Prevents Impaired Endothelium-Dependent Vasodilation Caused by Hyperglycemia in Humans , 2002, Circulation research.

[14]  J. Wilcox,et al.  Upregulation of Nox‐Based NAD(P)H Oxidases in Restenosis After Carotid Injury , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[15]  J. Warrington,et al.  Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real-time RT-PCR. , 2001, Analytical biochemistry.

[16]  T. Meinertz,et al.  Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.

[17]  D. Sorescu,et al.  Novel gp91phox Homologues in Vascular Smooth Muscle Cells: nox1 Mediates Angiotensin II-Induced Superoxide Formation and Redox-Sensitive Signaling Pathways , 2001, Circulation research.

[18]  T. Münzel,et al.  Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus , 2001, Circulation research.

[19]  K. Channon,et al.  Enhanced Superoxide Production in Experimental Venous Bypass Graft Intimal Hyperplasia: Role of NAD(P)H Oxidase , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[20]  D. Harrison,et al.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.

[21]  K. Channon,et al.  Functional Effect of the C242T Polymorphism in the NAD(P)H Oxidase p22phox Gene on Vascular Superoxide Production in Atherosclerosis , 2000, Circulation.

[22]  A. Shah,et al.  Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[23]  K. Channon,et al.  Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. , 2000, Circulation research.

[24]  A. Dominiczak,et al.  Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. , 2000, Circulation.

[25]  D. Sorescu,et al.  NAD(P)H oxidase: role in cardiovascular biology and disease. , 2000, Circulation research.

[26]  Y. Hayashi,et al.  Expression of NADH/NADPH oxidase p22phox in human coronary arteries. , 1999, Circulation.

[27]  D. Harrison,et al.  Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries. , 1999, Circulation.

[28]  D. Glogar,et al.  Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. , 1997, Atherosclerosis.

[29]  A. Yeung,et al.  Close relation of endothelial function in the human coronary and peripheral circulations. , 1995, Journal of the American College of Cardiology.